Profile
Full Name
Trevi Therapeutics, Inc.Ticker Symbol
TRVIExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 7, 2019Indexes
Not includedEmployees
26Key Details
Price
$6.47(+1.89%)
Market cap
$625.53M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.47(-62.07% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Trevi Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 8, 25 Needham
BuyMar 19, 25 Needham
BuyMar 19, 25 HC Wainwright & Co.
BuyMar 19, 25 D. Boral Capital
BuyMar 19, 25 B. Riley Securities
BuyMar 11, 25 Oppenheimer
OutperformMar 10, 25 Raymond James
Strong BuyMar 10, 25 Needham
BuyMar 10, 25 HC Wainwright & Co.
BuyMar 10, 25 D. Boral Capital
BuyInstitutional Ownership
- What is the ticker symbol for Trevi Therapeutics?
- Does Trevi Therapeutics pay dividends?
- What sector is Trevi Therapeutics in?
- What industry is Trevi Therapeutics in?
- What country is Trevi Therapeutics based in?
- When did Trevi Therapeutics go public?
- Is Trevi Therapeutics in the S&P 500?
- Is Trevi Therapeutics in the NASDAQ 100?
- Is Trevi Therapeutics in the Dow Jones?
- When was Trevi Therapeutics's last earnings report?
- When does Trevi Therapeutics report earnings?
- Should I buy Trevi Therapeutics stock now?
What is the ticker symbol for Trevi Therapeutics?
The ticker symbol for Trevi Therapeutics is NASDAQ:TRVI
Does Trevi Therapeutics pay dividends?
No, Trevi Therapeutics does not pay dividends
What sector is Trevi Therapeutics in?
Trevi Therapeutics is in the Healthcare sector
What industry is Trevi Therapeutics in?
Trevi Therapeutics is in the Biotechnology industry
What country is Trevi Therapeutics based in?
Trevi Therapeutics is headquartered in United States
When did Trevi Therapeutics go public?
Trevi Therapeutics's initial public offering (IPO) was on May 7, 2019
Is Trevi Therapeutics in the S&P 500?
No, Trevi Therapeutics is not included in the S&P 500 index
Is Trevi Therapeutics in the NASDAQ 100?
No, Trevi Therapeutics is not included in the NASDAQ 100 index
Is Trevi Therapeutics in the Dow Jones?
No, Trevi Therapeutics is not included in the Dow Jones index
When was Trevi Therapeutics's last earnings report?
Trevi Therapeutics's most recent earnings report was on Mar 18, 2025
When does Trevi Therapeutics report earnings?
The next expected earnings date for Trevi Therapeutics is May 7, 2025
Should I buy Trevi Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions